PE20050287A1 - Sistemas semi-solidos que contienen derivados de azetidina - Google Patents

Sistemas semi-solidos que contienen derivados de azetidina

Info

Publication number
PE20050287A1
PE20050287A1 PE2004000634A PE2004000634A PE20050287A1 PE 20050287 A1 PE20050287 A1 PE 20050287A1 PE 2004000634 A PE2004000634 A PE 2004000634A PE 2004000634 A PE2004000634 A PE 2004000634A PE 20050287 A1 PE20050287 A1 PE 20050287A1
Authority
PE
Peru
Prior art keywords
semi
systems containing
azetidine
solid systems
azetidine derivatives
Prior art date
Application number
PE2004000634A
Other languages
English (en)
Inventor
Valerie Bobineau
Maria-Teresa Peracchia
Sophie Cote
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PE20050287A1 publication Critical patent/PE20050287A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE AL MENOS UN DERIVADO DE AZETIDINA DE FORMULA GENERAL Ia o Ib, EN DONDE Ar ES UN GRUPO AROMATICO O HETEROAROMATICO OPCIONALMENTE SUSTITUIDO CON UNO O MAS GRUPOS ALQUILO C1-C4, HALOGENO, NO2, CN, ALCOXI C1-C4 o OH, OPCIONALMENTE EN COMBINACION CON OTRO INGREDIENTE ACTIVO QUE PUEDE POTENCIAR LOS EFECTOS DEL DERIVADO DE AZETIDINA DE FORMULA GENERAL Ia o Ib, EN UN SISTEMA QUE COMPRENDE UN MATERIAL SEMI-SOLIDO POLIMERICO SELECCIONADO DE VITAMINA E TPGS. TAMBIEN SE REFIERE A UN PROCESO PARA PREPARAR DICHA COMPOSICION Y UN KIT DE PRESENTACION. ESTOS DERIVADOS DE AZETIDINA SON AFINES AL RECEPTOR DE CANNABINOIDES Y EN PARTICULAR DE LOS RECEPTORES DE TIPO CB1
PE2004000634A 2003-07-18 2004-07-01 Sistemas semi-solidos que contienen derivados de azetidina PE20050287A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291796A EP1498122A1 (en) 2003-07-18 2003-07-18 Semi-solid systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
PE20050287A1 true PE20050287A1 (es) 2005-06-13

Family

ID=33462259

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004000634A PE20050287A1 (es) 2003-07-18 2004-07-01 Sistemas semi-solidos que contienen derivados de azetidina

Country Status (30)

Country Link
US (2) US20050026898A1 (es)
EP (2) EP1498122A1 (es)
JP (1) JP2009513560A (es)
KR (1) KR20060040691A (es)
CN (1) CN1822831A (es)
AR (1) AR045997A1 (es)
AU (1) AU2004262498B2 (es)
BR (1) BRPI0412737A (es)
CA (1) CA2532669A1 (es)
CR (1) CR8179A (es)
EC (1) ECSP066292A (es)
GT (1) GT200400135A (es)
HR (1) HRP20060022A2 (es)
IL (1) IL173111A0 (es)
MA (1) MA27922A1 (es)
MX (1) MXPA06000483A (es)
MY (1) MY142077A (es)
NO (1) NO20060509L (es)
OA (1) OA13191A (es)
PA (1) PA8606701A1 (es)
PE (1) PE20050287A1 (es)
RS (1) RS20060016A (es)
RU (1) RU2343915C2 (es)
SG (1) SG144141A1 (es)
TN (1) TNSN06013A1 (es)
TW (1) TW200522945A (es)
UA (1) UA80633C2 (es)
UY (1) UY28421A1 (es)
WO (1) WO2005013973A1 (es)
ZA (1) ZA200600490B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2007123366A (ru) * 2004-11-24 2008-12-27 Мерк Энд Ко. Жидкие и полутвердые фармацевтические препаративные формы для перорального введения замещенного амида
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
CN101926757B (zh) 2010-09-01 2013-01-02 北京大学 一种难溶性药物的液体组合物及其制备方法
EP2637655B1 (en) * 2010-11-08 2019-01-09 Cadila Pharmaceuticals Ltd. Pharmaceutical composition of taxoids
EP3086777A1 (en) * 2013-12-23 2016-11-02 Johnson & Johnson Consumer Inc. Racecadotril compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0825849A1 (en) * 1995-05-19 1998-03-04 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
EP1015046A2 (en) * 1998-07-14 2000-07-05 Em Industries, Inc. Microdisperse drug delivery systems
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives

Also Published As

Publication number Publication date
ZA200600490B (en) 2007-05-30
MXPA06000483A (es) 2006-04-05
AR045997A1 (es) 2005-11-23
AU2004262498B2 (en) 2009-01-22
TW200522945A (en) 2005-07-16
RS20060016A (en) 2008-06-05
AU2004262498A2 (en) 2005-02-17
AU2004262498A1 (en) 2005-02-17
US20080293686A1 (en) 2008-11-27
NO20060509L (no) 2006-01-31
TNSN06013A1 (en) 2007-10-03
PA8606701A1 (es) 2005-02-04
UY28421A1 (es) 2005-02-28
CA2532669A1 (en) 2005-02-17
BRPI0412737A (pt) 2006-09-26
RU2343915C2 (ru) 2009-01-20
JP2009513560A (ja) 2009-04-02
HRP20060022A2 (en) 2006-02-28
CR8179A (es) 2006-09-22
SG144141A1 (en) 2008-07-29
OA13191A (en) 2006-12-13
RU2006105011A (ru) 2006-06-10
UA80633C2 (en) 2007-10-10
CN1822831A (zh) 2006-08-23
MY142077A (en) 2010-08-30
US20050026898A1 (en) 2005-02-03
KR20060040691A (ko) 2006-05-10
MA27922A1 (fr) 2006-06-01
GT200400135A (es) 2005-08-25
WO2005013973A1 (en) 2005-02-17
EP1648442A1 (en) 2006-04-26
IL173111A0 (en) 2006-06-11
EP1498122A1 (en) 2005-01-19
ECSP066292A (es) 2006-10-25

Similar Documents

Publication Publication Date Title
CR8766A (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
AR063602A1 (es) Derivados de espiroindolinona, formulaciones farmaceuticas que los contienen y su uso en la obtencion de un medicamento para el tratamiento de trastornos oncologicos.
UY28026A1 (es) 4-piperazinilbencenosulfonilindoles y usos de los mismos.
DE60021282D1 (de) Carbamat-derivate als muscarin-rezeptor antonisten
DK1697370T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
DK1506185T3 (da) Forbindelser og deres anvendelse som 5-HT-inhibitorer
SV2008002828A (es) Agentes para prevenir y tratar trastornos que involucran la modulacion de los receptores ryr ref. 19240-619-sv1
SV2004001690A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos
ES2139959T3 (es) Derivados de estilbeno utiles como inhibidores de la ciclooxigenasa-2.
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
ATE496620T1 (de) 1h-benzo(f)indazol-5-yl-derivate als selektive glucocorticoid-rezeptor-modulatoren
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
GT200500119A (es) Derivados de tetraazabenzo [e] azuleno y sus analogos
UY29087A1 (es) Derivados de adamantilo, composiciones farmaceuticas que los contienen, procesos para su preparacion y uso terapeutico
ECSP045004A (es) Inhibidores de la 17beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades andrógeno dependientes
GT200900283A (es) "terapia de combinación con un compuesto actuando como un inhibidor del receptor adp plaquetario".
SV2007002526A (es) Diarilsulfona sulfonamidas y el uso de las mismas ref. p1018
SV2003001089A (es) Agentes antibacterianos pc20512
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
BRPI0417161A (pt) compostos, composições farmacêuticas, e, uso de um composto
PA8605101A1 (es) 4-(aminometil)-piperidin benzamidas como antagonista de 5ht4
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
CO5590911A2 (es) Composiciones farmaceuticas a base de derivados de azetidina
DOP2010000197A (es) Derivados de oxindol sustituidos y uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina
PA8633601A1 (es) Profarmacos de esteroides con accion androgenica

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed